检索

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan

The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies

Klimova A., Ambatello L., Smolyakova E., Nistor S., Zykov K., Chazova I.

(Rus)

卷 14, 编号 2 (2017)

Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)

Oshchepkova E., Lazareva N., Chazova I.

(Rus)

卷 14, 编号 1 (2017)

Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study)

Efremova Y., Oshchepkova E., Zhernakova Y., Chazova I., Iarovaia E., Shalnova S., Rotar O., Konradi A., Shliakhto E., Boitsov S.

(Rus)

卷 13, 编号 4 (2016)

Radiofrequency renal arteries denervation: effectively and safely

Grigin V., Danilov N., Matchin Y., Chazova I.

(Rus)

卷 13, 编号 3 (2016)

Zhernakova Y., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

Safety of beta-agonists with different duration of action in patients with arterial hypertension and broncho-obstructive diseases

Dolgusheva Y., Agapova O., Zykov K., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

Calcium channel blockers: more than 50 years on guard of health

Chazova I., Zhernakova Y.

(Rus)

卷 11, 编号 4 (2014)

First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension

Ostroumova O.

(Rus)

卷 11, 编号 3 (2014)

Education and self-education of the patients is an important step towards increasing patients acceptance of therapy

Chazova I., Ageev F., Fofanova T., Chikhladze N., Kuznetsova M., Smirnova M., Ostrogorskaya V., Geraschenko Y.

(Rus)

卷 10, 编号 3 (2013)

Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma

Sharipova G., Chazova I., Zhernakova Y.

卷 10, 编号 1 (2013)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension

Glukhova T., Solgalova S., Alferov V.

卷 9, 编号 4 (2012)

Stress-induced arterial hypertension – clinical features and treatment options

Ratova L., Chazova I.

卷 3, 编号 2 (2006)

Novye vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom (rezul'taty issledovaniya ALMAZ)

Chazova I., Mychka V.

卷 2, 编号 2 (2005)

Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa

Volkova E.

卷 2, 编号 2 (2005)

Podkhody k lecheniyu arterial'noy gipertonii v usloviyakh statsionara: korrektsiya arterial'nogo davleniya i sostoyanie kognitivnykh funktsiy

Ostroumova O., Desnitskaya I.

Vliyanie terapii bisoprololom i aktoveginom na perfuziyu golovnogo mozga u patsientov s metabolicheskim sindromom

Mychka V., Chazova I., Gornostaev V., Sergienko V.

卷 1, 编号 2 (2004)

Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA)

Chazova I., Belenkov Y.

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

Povyshenie arterial'nogo davleniya i gipotenzivnaya terapiya pri insul'te

Parfenov V.

卷 18, 编号 1 (2021)

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 17, 编号 3 (2020)

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 6, 编号 3 (2009)

Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy.

Ryabykina G., Shishova T., Laptev D., Mychka V., Lyutikova L., Kozhemyakina E., Shchedrina E., Sobolev A., Chazova I.

卷 15, 编号 4 (2018)

Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes

Kovalenko F., Skibitsky V., Fendrikova A.

(Rus)

卷 15, 编号 2 (2018)

Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion

Litvin A., Elfimova E., Chazova I.

(Rus)

卷 14, 编号 3 (2017)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders

Chazova I., Zhernakova Y., Blinova N., Rogoza A.

(Rus)

卷 13, 编号 4 (2016)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide

Ostroumova O., Garelik I., Karavashkina E.

(Rus)

卷 12, 编号 2 (2015)

The hardness of the vessel wall in patients with arterial hypertension

Ostroumova O., Kochetkov A., Kopchenov I., Guseva T., Bondarec O.

(Rus)

The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 10, 编号 4 (2013)

The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District

Chazova I., Trubacheva I., Zhernakova Y., Oshchepkova E., Serebriakova V., Kaveshnikov V., Karpov R.

卷 10, 编号 2 (2013)

Efficacy of irbesartan in arterial hypertension and metabolic syndrome

Ostroumova O., Zykova A., Polosova T., Bondarets O.

卷 10, 编号 1 (2013)

The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)

Chazova I., Chuchalin A., Zykov K., Ratova L.

卷 6, 编号 2 (2009)

HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association

卷 3, 编号 2 (2006)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom

Chazova I., Martynyuk T.

Kogda neobkhodimo nachinat' lechenie arterial'noy gipertonii s fiksirovannykh kombinatsiy? Novye tendentsii

Ostroumova O., Golovina O.

Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?

Shestakova M.

Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)

Chazova I.

Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey

Chikhladze N., Chazova I.

卷 17, 编号 4 (2020)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

Pinchuk T., Orlova N.

(Rus)

卷 16, 编号 2 (2019)

Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity

Zhernakova J., Zheleznova E., Chazova I., Blinova N., Ivanov K., Starodubova A.

(Rus)

卷 16, 编号 4 (2019)

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

Chazova I., Zhernakova J., Kisliak O., Nedogoda S., Podzolkov V., Oshchepkova E., Medvedeva I., Mironova O., Blinova N.

(Rus)

卷 15, 编号 4 (2018)

Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension

Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.

(Rus)

The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results

Zhernakova Y., Chazova I., Oshchepkova E., Shalnova S., Konradi A., Rotar O., Yarovaya E., Shlyahto E., Boitsov S.

(Rus)

Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers

Ostroumova O., Kochetkov A.

(Rus)

卷 14, 编号 3 (2017)

Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level

Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.

(Rus)

卷 14, 编号 2 (2017)

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment

Temnikova E.

(Rus)

卷 13, 编号 3 (2016)

Prolonged release verapamil: application in clinical practice

Gaponova N., Abdrakhmanov V.

(Rus)

卷 12, 编号 1 (2015)

The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome

Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.

(Rus)

卷 11, 编号 2 (2014)

Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders

Zhernakova Y., Chazova I.

(Rus)

Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)

Hypertension treatment features in perimenopausal women

Zhernakova Y., Chazova I.

(Rus)

卷 10, 编号 3 (2013)

Vliyanie raznykh skhem antigipertenzivnoy terapii s dostizheniem tselevykh znacheniy arterial'nogo davleniya na sostoyanie funktsii pochek i vnutripochechnoe sosudistoe soprotivlenie u bol'nykh sakharnym diabetom tipa 2

Koshel'skaya O., Zhuravleva O., Karpov R.

卷 10, 编号 3 (2013)

Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii

Shilov A.

卷 3, 编号 2 (2006)

Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii

Galyavich A.

卷 2, 编号 2 (2005)

Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta

Gorokhovskaya G., Petina M., Akatova E., Aksenov I., Martynov A.

卷 1, 编号 2 (2004)

Samokontrol' arterial'nogo davleniya patsientami povyshaet priverzhennost' k lecheniyu arterial'noy gipertonii (nablyudenie 1 god)

Oshchepkova E., Tsagareishvili E., Rogoza A.

卷 1, 编号 2 (2004)

Pervye rezul'taty Rossiyskoy programmy po izucheniyu effektivnosti primeneniya akarbozy u patsientov s narushennoy tolerantnost'yu k glyukoze i arterial'noy gipertoniey (APREL')

Chazova I., Mychka V., Belenkov Y.

卷 18, 编号 3 (2021)

Management of patients with arterial hypertension and atrial fibrillation

Chazova I., Golitsyn S., Zhernakova J., Zheleznova E., Kropacheva E., Mironov N., Kostiukevich M., Laiovich L., Utsumueva M., Iuricheva I., Litvin A., Elfimova E., Rogoza A., Panchenko E.

(Rus)

卷 17, 编号 4 (2020)

Primary hyperaldosteronism as a possible cause of resistant arterial hypertension

Chikhladze N.

(Rus)

卷 17, 编号 1 (2020)

Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up

Agaeva R., Danilov N., Shchcelkova G., Matchin Y., Chazova I.

(Rus)

卷 16, 编号 3 (2019)

Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]

Blinova E., Sakhnova T., Chaykovskaya O., Saidova M., Ryabykina G.

(Rus)

卷 6, 编号 4 (2009)

Chazova I., Ostroumova O.

The place of intervention methods of treatment of patients with resistant hypertension in clinical practice

Agaeva R., Danilov N., Sagaydak O., Chazova I.

(Rus)

卷 14, 编号 1 (2017)

Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients

Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.

(Rus)

卷 13, 编号 4 (2016)

Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension

Shchelkova G., Zairova A., Danilov N., Rogoza A., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

The role of beta-blockers in the treatment of arterial hypertension: what do we know today

Zhernakova Y., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target?

Kobalava Z., Shavarova E.

(Rus)

卷 11, 编号 4 (2014)

Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension

Vakhovskaya T., Tripoten M., Pogorelova O., Balakhonova T., Loukianov M., Boytsov S.

(Rus)

卷 11, 编号 4 (2014)

Methods of sympathetic activity evaluation in patients with systemic refractory hypertension

Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.

(Rus)

卷 11, 编号 2 (2014)

The benefits of candesartan usage in the treatment of arterial hypertension

Ostroumova O., Bondarets O., Guseva T.

(Rus)

Experience of treating hypertension in an outpatient setting: a clinical case

Agafonov A., Khozyainova N., Petruschenkova O.

(Rus)

Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

卷 10, 编号 4 (2013)

Coagulogic risk factors of heart disease in the adult population of Tomsk

Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.

卷 10, 编号 2 (2013)

A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs

Titov V.

Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)

Chazova I., Ratova L.

Gipotenzivnaya effektivnost' novoy lekarstvennoy formy metoprolola zamedlennogo vysvobozhdeniya u bol'nykh s arterial'noy gipertoniey

Belousov Y., Leonova M., Erofeeva S.